Performance of the Glucose Management Indicator (GMI) in Type 2 Diabetes.

Michael FangDan WangMary R Rooney Justin Basile Echouffo-TcheuguiJosef CoreshR Nisha AuroraNaresh M PunjabiElizabeth Selvin

Published in: Clinical chemistry (2023)

GMI may be an unreliable measure of glycemic control for patients with type 2 diabetes and should be interpreted cautiously in clinical practice.Clinicaltrials.gov Registration Number: NCT02454153.

Keyphrases

glycemic control
type diabetes
blood glucose
clinical practice
weight loss
insulin resistance
cardiovascular disease
metabolic syndrome
skeletal muscle